The biopharmaceutical company posted a loss of $11.5 million, or nine cents a share, compared with a loss of $41.7 million, or 35 cents a share, a year earlier. Analysts polled by FactSet had expected ...
Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback